Hologic Inc (HOLX)

Working capital turnover

Sep 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019
Revenue (ttm) US$ in thousands 4,030,300 3,960,600 3,969,300 4,030,400 4,038,300 4,056,600 4,465,800 4,862,700 5,226,100 5,391,700 5,493,600 5,632,300 5,662,700 5,317,300 4,535,800 3,776,500 3,295,300 3,324,800 3,387,100 3,367,300
Total current assets US$ in thousands 3,823,300 3,788,700 3,494,200 4,184,500 4,339,300 4,211,400 4,021,200 3,862,000 3,909,000 3,881,400 3,506,200 3,168,700 2,418,200 2,662,400 2,596,300 2,222,300 1,982,800 1,936,600 1,637,600 1,793,100
Total current liabilities US$ in thousands 1,037,200 954,600 899,000 1,207,300 981,300 955,000 956,200 937,700 1,000,900 1,305,100 1,278,700 1,326,800 1,464,600 1,036,400 1,056,000 1,239,300 1,345,700 1,480,900 1,043,300 1,070,100
Working capital turnover 1.45 1.40 1.53 1.35 1.20 1.25 1.46 1.66 1.80 2.09 2.47 3.06 5.94 3.27 2.94 3.84 5.17 7.30 5.70 4.66

September 30, 2024 calculation

Working capital turnover = Revenue (ttm) ÷ (Total current assets – Total current liabilities)
= $4,030,300K ÷ ($3,823,300K – $1,037,200K)
= 1.45

The working capital turnover ratio for Hologic Inc has fluctuated over the years, indicating changes in how efficiently the company is utilizing its working capital to generate sales revenue.

The ratio has ranged from a low of 1.20 in June 2023 to a high of 7.30 in September 2019. A lower ratio suggests that the company is taking longer to convert its working capital into sales, which may indicate inefficiencies in managing its current assets and liabilities.

On the other hand, a higher ratio indicates that the company is more effectively using its working capital to generate sales. Hologic Inc saw a significant improvement in its working capital turnover ratio from 2019 to 2021, indicating a more efficient use of its resources during that period.

However, the ratio has decreased in recent quarters, potentially signaling challenges in managing working capital effectively or changes in the company's operating environment. It would be important for Hologic Inc to closely monitor and address any factors affecting its working capital turnover to ensure optimal operational performance and financial health.


Peer comparison

Sep 30, 2024

Company name
Symbol
Working capital turnover
Hologic Inc
HOLX
1.45
GE HealthCare Technologies Inc.
GEHC
44.18